SIGLEC1 and colorectal carcinoma: We found a significant positive correlation between SIGLEC1 expression and inhibitory/co-inhibitory immune genes, which further emphasizes the potential role of SIGLEC1 in CRC immune evasion and immunotherapy resistance.